INTRINSIC MOLECULAR SUBTYPES OF GLIOMA ARE PROGNOSTIC AND PREDICT BENEFIT FROM ADJUVANT PCV CHEMOTHERAPY IN ANAPLASTIC OLIGODENDROGLIAL BRAIN TUMORS : A REPORT FROM EORTC STUDY 26951